CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,047,939 | -15.7% | 67,150 | +4.2% | 0.00% | 0.0% |
Q2 2023 | $3,617,382 | +30.9% | 64,435 | +5.5% | 0.00% | 0.0% |
Q1 2023 | $2,763,282 | +23.5% | 61,094 | +11.0% | 0.00% | 0.0% |
Q4 2022 | $2,237,985 | -37.1% | 55,055 | +1.1% | 0.00% | 0.0% |
Q3 2022 | $3,557,000 | +5.8% | 54,436 | -1.6% | 0.00% | 0.0% |
Q2 2022 | $3,361,000 | +1.7% | 55,306 | +5.0% | 0.00% | 0.0% |
Q1 2022 | $3,306,000 | -16.1% | 52,677 | +1.3% | 0.00% | 0.0% |
Q4 2021 | $3,940,000 | -26.2% | 52,002 | +9.0% | 0.00% | -50.0% |
Q3 2021 | $5,338,000 | -7.8% | 47,691 | +33.3% | 0.00% | 0.0% |
Q2 2021 | $5,790,000 | +43.0% | 35,765 | +7.6% | 0.00% | 0.0% |
Q1 2021 | $4,050,000 | -10.0% | 33,235 | +13.1% | 0.00% | 0.0% |
Q4 2020 | $4,499,000 | +75.7% | 29,381 | -4.0% | 0.00% | +100.0% |
Q3 2020 | $2,560,000 | +32.1% | 30,599 | +16.0% | 0.00% | 0.0% |
Q2 2020 | $1,938,000 | +352.8% | 26,378 | +190.6% | 0.00% | – |
Q1 2020 | $428,000 | -79.2% | 9,077 | -73.2% | 0.00% | -100.0% |
Q4 2019 | $2,060,000 | +4581.8% | 33,830 | +3018.0% | 0.00% | – |
Q3 2019 | $44,000 | -13.7% | 1,085 | 0.0% | 0.00% | – |
Q2 2019 | $51,000 | +168.4% | 1,085 | +100.9% | 0.00% | – |
Q1 2019 | $19,000 | +26.7% | 540 | 0.0% | 0.00% | – |
Q4 2018 | $15,000 | +87.5% | 540 | +182.7% | 0.00% | – |
Q3 2018 | $8,000 | -27.3% | 191 | 0.0% | 0.00% | – |
Q2 2018 | $11,000 | – | 191 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |